Neutralization of ROS by this enzyme is related to decreased glucose-dependent kidney and vascular damage, which suggests that GPx3 exerts an crucial role against oxidative stress and it may act as a potential therapeutic target for diabetic kidney disease [35, 36]. The gene discussed is GPX3; the disease is diabetic kidney disease.